Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Cantor Fitzgerald
Cipla
Boehringer Ingelheim
Healthtrust
Johnson and Johnson
Accenture
Federal Trade Commission

Generated: October 21, 2018

DrugPatentWatch Database Preview

Mechanism of Action: Dopamine D2 Antagonists

« Back to Dashboard

Drugs with Mechanism of Action: Dopamine D2 Antagonists

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms REGLAN metoclopramide hydrochloride TABLET;ORAL 017854-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms REGLAN metoclopramide hydrochloride TABLET;ORAL 017854-002 May 5, 1987 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 073118-001 Jan 17, 1991 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride SOLUTION;ORAL 071402-001 Jun 25, 1993 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm Inc METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 070581-001 Oct 17, 1985 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 070184-001 Jul 29, 1985 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ipca Labs Ltd METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 078807-001 Jun 12, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Argus Health
Daiichi Sankyo
UBS
AstraZeneca
Citi
US Army
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.